American Century Companies Inc. Sells 139,677 Shares of Oscar Health, Inc. (NYSE:OSCR)

American Century Companies Inc. decreased its position in shares of Oscar Health, Inc. (NYSE:OSCR) by 73.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 49,725 shares of the company’s stock after selling 139,677 shares during the period. American Century Companies Inc.’s holdings in Oscar Health were worth $787,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in OSCR. TD Asset Management Inc boosted its stake in shares of Oscar Health by 71.9% during the fourth quarter. TD Asset Management Inc now owns 195,600 shares of the company’s stock valued at $1,790,000 after purchasing an additional 81,800 shares in the last quarter. Focus Financial Network Inc. ADV bought a new stake in Oscar Health in the fourth quarter worth approximately $152,000. NEOS Investment Management LLC bought a new stake in Oscar Health in the fourth quarter worth approximately $205,000. Ratan Capital Management LP increased its holdings in Oscar Health by 45.0% in the fourth quarter. Ratan Capital Management LP now owns 203,114 shares of the company’s stock worth $1,858,000 after purchasing an additional 63,028 shares in the last quarter. Finally, Symmetry Peak Management LLC bought a new stake in Oscar Health in the fourth quarter worth approximately $488,000. Institutional investors own 75.70% of the company’s stock.

Analyst Upgrades and Downgrades

OSCR has been the subject of a number of research reports. Wells Fargo & Company raised their price objective on Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a research note on Wednesday, June 12th. Piper Sandler reissued an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a research note on Tuesday, September 10th. Two analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Oscar Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $24.17.

Oscar Health Stock Down 2.7 %

Shares of NYSE:OSCR opened at $20.63 on Wednesday. The stock has a market cap of $4.89 billion, a price-to-earnings ratio of -51.58, a PEG ratio of 43.01 and a beta of 1.61. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 12-month low of $4.72 and a 12-month high of $23.79. The business’s 50 day moving average is $18.70 and its 200 day moving average is $17.93.

Oscar Health (NYSE:OSCR) last announced its earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.04. The company had revenue of $2.20 billion for the quarter, compared to analysts’ expectations of $2.13 billion. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. Oscar Health’s quarterly revenue was up 44.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.07) earnings per share. On average, sell-side analysts forecast that Oscar Health, Inc. will post 0.01 earnings per share for the current fiscal year.

Insider Activity at Oscar Health

In other Oscar Health news, EVP Alessandrea C. Quane sold 16,793 shares of the business’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $17.06, for a total value of $286,488.58. Following the transaction, the executive vice president now owns 392,607 shares of the company’s stock, valued at $6,697,875.42. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Oscar Health news, insider Mario Schlosser sold 3,198 shares of the business’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $57,532.02. Following the sale, the insider now directly owns 76,982 shares in the company, valued at $1,384,906.18. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Alessandrea C. Quane sold 16,793 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $17.06, for a total value of $286,488.58. Following the completion of the sale, the executive vice president now owns 392,607 shares in the company, valued at $6,697,875.42. The disclosure for this sale can be found here. Insiders have sold a total of 169,569 shares of company stock valued at $3,007,069 over the last 90 days. Insiders own 25.11% of the company’s stock.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.